ADMA Biologics, Inc.

ADMA Biologics is a commercial biopharmaceutical company dedicated to the development and commercialization of specialty plasma-derived products. They specialize in manufacturing, marketing, and developing these products for the prevention and treatment of infectious diseases, particularly focusing on immune-compromised patients and those at risk for certain infections. ADMA Biologics is the only US-domiciled producer of plasma-derived therapeutics and has three FDA-approved products: ASCENIV™, BIVIGAM®, and NABI-HB®. Their commitment to these underserved populations is evident in their hands-on approach to production and development, and they also offer a comprehensive suite of CDMO and CMO opportunities.

ADMA Biologics prides itself on its vertically integrated, end-to-end manufacturing process, ensuring control over the entire supply chain, from plasma collection to fill-finish capabilities. They have a robust manufacturing plant with a high annual plasma fractionation and purification capacity. In addition to their focus on quality and safety, ADMA Biologics is known for its patented immunotechnology, which involves a proprietary microneutralization assay to identify hyperimmune donors with high-titer antibodies. This allows them to produce tailored plasma pools for specific pathogens, resulting in more effective treatments for patients. Their dedication to innovation, ethical business practices, and patient advocacy solidifies ADMA Biologics as a leader in the plasma-derived therapeutic industry.

ADMA Biologics offers a competitive benefits package that includes comprehensive healthcare coverage, customizable medical, dental, and vision plans, and health savings accounts. The company also provides employer-paid life insurance and accidental death or dismemberment insurance, a 401k plan with a 4% employer match and immediate vesting, long- and short-term disability, and financial advisor services. ADMA also offers tuition reimbursement, paid time off, company-paid holidays, pet insurance, and comfortable working conditions in modern, air-conditioned facilities.

ADMA Biologics is a biopharmaceutical company dedicated to the development and commercialization of specialty plasma-derived products. Their mission is to improve the lives of immune-compromised patients and those at risk for certain infections through the manufacturing, marketing, and development of innovative plasma-derived therapies. They strive to lead a new age of plasma-derived products with proven immunotechnology by providing high-quality, safe, and effective treatment options for patients with primary immunodeficiency diseases and other immune-compromised populations.

ADMA Biologics cultivates a culture that prioritizes human connection, both within the company and with its patients. Collaboration is highly encouraged, fostering an environment of open communication and shared accountability. The company embraces a dynamic approach, constantly striving to translate groundbreaking science into meaningful actions. ADMA Biologics values tenacity, demonstrating unwavering commitment to excellence in their pursuit of improving lives. This combination of human-centered values, collaborative spirit, and relentless drive creates a culture where employees feel valued, empowered, and dedicated to making a real impact in the world.

ADMA Biologics emphasizes a culture of human connection, collaboration, and inclusion. They are committed to fostering a diverse workforce and creating a workplace where everyone feels valued and respected. They promote open communication, teamwork, and shared accountability, leveraging the strengths of all individuals to drive innovation and achieve their goals.